ScholarIQanswers from OpenAlex & ORCID
Jin‐Ji Yang
ResearcherPublications, citations & collaboration network
Jin‐Ji Yang is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jin‐Ji Yang have?
ScholarIQindexed works
Jin‐Ji Yang has 289 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jin‐Ji Yang have?
ScholarIQcitation count
Jin‐Ji Yang has 9,155 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jin‐Ji Yang?
ScholarIQh-index
Jin‐Ji Yang has an h-index of 50 in OpenAlex.
What is the i10-index of Jin‐Ji Yang?
ScholarIQi10-index
Jin‐Ji Yang has an i10-index of 111 in OpenAlex.
What is the ORCID of Jin‐Ji Yang?
ScholarIQorcid
The ORCID for Jin‐Ji Yang is on the source record.
What is the OpenAlex record for Jin‐Ji Yang?
ScholarIQopenalex
The OpenAlex for Jin‐Ji Yang is on the source record.
What are the most-cited papers on Jin‐Ji Yang?
ScholarIQmost cited works
Potential Predictive Value of <i>TP53</i> and <i>KRAS</i> Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
Zhong‐Yi Dong, Wen‐Zhao Zhong, Xu‐Chao Zhang, Jian Su, Zhi Xie, Si‐Yang Maggie Liu, Hai‐Yan Tu, Hua‐Jun Chen, Yue‐Li Sun, Qing Zhou, Jin‐Ji Yang, Xue‐Ning Yang, Jiaxin Lin, Hong‐Hong Yan, Hao-Ran Zhai, Li‐Xu Yan, Ri-Qiang Liao, Si-Pei Wu, Yi‐Long Wu
Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy
Y.S. Li, Bo Jiang, Jin‐Ji Yang, X.C. Zhang, Zhou Zhang, J.Y. Ye, Wen‐Zhao Zhong, Hai‐Yan Tu, H.J. Chen, Z. Wang, Chong‐Rui Xu, B.C. Wang, Hao Du, Shaokun Chuai, Han Han‐Zhang, Jian Su, Qing Zhou, Xue‐Ning Yang, Wanting Guo, Hong‐Hong Yan, Y.H. Liu, Li‐Xu Yan, Biao Huang, Mei-Mei Zheng, Yi‐Long Wu
Leptomeningeal Metastases in Patients with NSCLC with EGFR Mutations
Yang-Si Li, Ben‐Yuan Jiang, Jin‐Ji Yang, Hai‐Yan Tu, Qing Zhou, Wei‐Bang Guo, Hong‐Hong Yan, Yi‐Long Wu
Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression
Xu‐Chao Zhang, Shirley Zhang, Xue‐Ning Yang, Jin‐Ji Yang, Qing Zhou, Lucy Yin, Shejuan An, Jia-Yin Lin, Shiliang Chen, Zhi Xie, Mike Zhu, Xiaolin Zhang, Yi‐Long Wu
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial
Wen-Zhao Zhong, Qun Wang, Weimin Mao, Lin Xu, Lin Wu, Yucheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Shengxiang Ren, Xiaofei Li, Jian Li, Cheng Huang, Zhidong Liu, Shun Xu, Ke‐Neng Chen, Shidong Xu, Lunxu Liu, Ping Yu, Buhai Wang, Haitao Ma, Jin‐Ji Yang, Hong‐Hong Yan, Xue‐Ning Yang, Si‐Yang Liu, Qing Zhou, Yi‐Long Wu